Drugs / HUC3-637
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07335211 | Jan 2026 → Nov 2027 expected | ocular hypertension, open-angle glaucoma | Huons Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HUC3-637 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07335211 ↗ |
| Route | Topical | “Ophthalmic solution instilled directly into the eye (topical ocular administration)” NCT07335211 ↗ |